Liver transplantation for children with biliary atresia in the pediatric end-stage liver disease era: The role of insurance status

被引:21
作者
Arnon, Ronen [1 ,2 ]
Annunziato, Rachel A. [3 ]
Willis, Asha [4 ]
Parbhakar, Meera [3 ]
Chu, Jaime [1 ,2 ]
Kerkar, Nanda [1 ,2 ]
Shneider, Benjamin L. [5 ]
机构
[1] Mt Sinai Med Ctr, Recanati Miller Transplantat Inst, New York, NY 11029 USA
[2] Mt Sinai Med Ctr, Dept Pediat, New York, NY 11029 USA
[3] Fordham Univ, Dept Psychol, Bronx, NY 10458 USA
[4] Maimonides Infants & Childrens Hosp Brooklyn, Dept Pediat, New York, NY USA
[5] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Dept Pediat, Pittsburgh, PA 15213 USA
关键词
ETHNIC-MINORITIES; UNITED-STATES; OUTCOMES; ASSOCIATION; DISPARITIES; RECIPIENTS; PATTERNS; CANCER; ACCESS; VOLUME;
D O I
10.1002/lt.23607
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Socioeconomic status influences health outcomes, although its impact on liver transplantation (LT) in children with biliary atresia (BA) is unknown. We hypothesized that governmental insurance [public insurance (PU)], rather than private insurance (PR), would be associated with poorer outcomes for children with BA. Children with BA who underwent first isolated LT between January 2003 and June 2011 were identified from United Network for Organ Sharing Standard Transplant Analysis and Research files. We identified 757 patients with PR and 761 patients with PU. The race/ethnicity distribution was significantly different between the groups (65% white, 12% black, and 10% Hispanic in the PR group and 33% white, 26% black, and 29% Hispanic in the PU group, P<0.01). Wait-list mortality was higher for the PU group versus the PR group [46/1654 (2.7%) versus 29/1895 (1.5%), P<0.01]. PR patients were older than PU patients at transplant (2.4 +/- 4.5 versus 1.5 +/- 3.0 years, P<0.01). The donor types differed between the groups: 165 children (21.8%) in the PR group received living donor grafts, whereas 79 children (10.4%) in the PU group did (P<0.01). The 1- and 5-year posttransplant patient survival rates were greater for the PR group versus the PU group (98.0% versus 94.1% at 1 year, P<0.01; 97.8% versus 92.2% at 5 years, P<0.01). Cox proportional hazards models revealed that the insurance type (PU), the donor type (deceased), and life support were significant risk factors for death. A separate analysis of deceased donor LT revealed that the PU group still had significantly worse patient and graft survival. In conclusion, PU coverage is an independent risk factor for significantly increased wait-list and posttransplant mortality in children with BA. Further studies are needed to unearth the reasons for these important differences in outcomes. Liver Transpl 19:543550, 2013. (c) 2013 AASLD.
引用
收藏
页码:543 / 550
页数:8
相关论文
共 20 条
[1]   Association of center volume with outcome after liver and kidney transplantation [J].
Axelrod, DA ;
Guidinger, MK ;
McCullough, KP ;
Leichtman, AB ;
Punch, JD ;
Merion, RM .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (06) :920-927
[2]   Orthotopic liver transplantation for biliary atresia: The US experience [J].
Barshes, NR ;
Lee, TC ;
Balkrishnan, R ;
Karpen, SJ ;
Carter, BA ;
Goss, JA .
LIVER TRANSPLANTATION, 2005, 11 (10) :1193-1200
[3]   Socioeconomic Disparities in Health in the United States: What the Patterns Tell Us [J].
Braveman, Paula A. ;
Cubbin, Catherine ;
Egerter, Susan ;
Williams, David R. ;
Pamuk, Elsie .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2010, 100 :S186-S196
[4]   Long-Term Outcomes in Pediatric Liver Transplantation [J].
Bucuvalas, John .
LIVER TRANSPLANTATION, 2009, 15 (11) :S6-S11
[5]  
CHIRIKOS TN, 1985, CANCER-AM CANCER SOC, V56, P210, DOI 10.1002/1097-0142(19850701)56:1<210::AID-CNCR2820560136>3.0.CO
[6]  
2-E
[7]   Pediatric liver transplantation for biliary atresia: Results of primary grafts in 328 recipients [J].
Diem, HVT ;
Evrard, V ;
Vinh, HT ;
Sokal, EM ;
Janssen, M ;
Otte, JB ;
Reding, R .
TRANSPLANTATION, 2003, 75 (10) :1692-1697
[8]   Underuse of controller medications among Medicaid-insured children with asthma [J].
Finkelstein, JA ;
Lozano, P ;
Farber, HJ ;
Miroshnik, I ;
Lieu, TA .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2002, 156 (06) :562-567
[9]  
FREEMAN HP, 1989, CANCER, V64, P324, DOI 10.1002/1097-0142(19890701)64:1+<324::AID-CNCR2820641334>3.0.CO
[10]  
2-B